Aims: Although pivotal trials have established efficacy in weight reduction during the use of GLP-1 based therapies, daily fluctuations in food-related experiences between scheduled assessments remain to be better characterized. We therefore aimed to assess day-to-day patterns in food noise, cravings, hunger, satiety, and fullness among adults receiving weekly semaglutide or tirzepatide for weight management. Materials and Methods: This prospective, direct-to-participant, US observational study enrolled adults receiving weekly subcutaneous semaglutide or tirzepatide for weight management with
Patient-Reported Food Noise, Cravings and Appetite in Adults with Obesity Treated with Weekly Injectable GLP-1 Based Therapies: A Prospective Real-World Study
calendar_today
November 13, 2026
person
Le Roux, C., Kalich, B., Muhammad, C., Horn, D., Orroth, K., Boer, L., Wang, M.-J., Tahrani, A. A., Avcil, S., Nguyen, L., Li, Z.-R., Fabiano, S., Gibson, C. M., Kang, Y. M.
domain
medrxiv